1.Interferon-γ regulates cell malignant growth via the c-Abl/HDAC2 signaling pathway in mammary epithelial cells.
Wen-Bo REN ; Xiao-Jing XIA ; Jing HUANG ; Wen-Fei GUO ; Yan-Yi CHE ; Ting-Hao HUANG ; Lian-Cheng LEI
Journal of Zhejiang University. Science. B 2019;20(1):39-48
Interferon-γ (IFN-γ) has been used to control cancers in clinical treatment. However, an increasing number of reports have suggested that in some cases effectiveness declines after a long treatment period, the reason being unclear. We have reported previously that long-term IFN-γ treatment induces malignant transformation of healthy lactating bovine mammary epithelial cells (BMECs) in vitro. In this study, we investigated the mechanisms underlying the malignant proliferation of BMECs under IFN-γ treatment. The primary BMECs used in this study were stimulated by IFN-γ (10 ng/mL) for a long term to promote malignancy. We observed that IFN-γ could promote malignant cell proliferation, increase the expression of cyclin D1/cyclin-dependent kinase 4 (CDK4), decrease the expression of p21, and upregulate the expression of cellular-abelsongene (c-Abl) and histone deacetylase 2 (HDAC2). The HDAC2 inhibitor, valproate (VPA) and the c-Abl inhibitor, imatinib, lowered the expression level of cyclin D1/CDK4, and increased the expression level of p21, leading to an inhibitory effect on IFN-γ-induced malignant cell growth. When c-Abl was downregulated, the HDAC2 level was also decreased by promoted proteasome degradation. These data suggest that IFN-γ promotes the growth of malignant BMECs through the c-Abl/HDAC2 signaling pathway. Our findings suggest that long-term application of IFN-γ may be closely associated with the promotion of cell growth and even the carcinogenesis of breast cancer.
Animals
;
Carcinogenesis/pathology*
;
Cattle
;
Cell Cycle Proteins/metabolism*
;
Cell Proliferation/drug effects*
;
Cell Transformation, Neoplastic/pathology*
;
Cells, Cultured
;
Epithelial Cells/pathology*
;
Female
;
Histone Deacetylase 2/metabolism*
;
Imatinib Mesylate/pharmacology*
;
Interferon-gamma/pharmacology*
;
Mammary Glands, Animal/pathology*
;
Mammary Neoplasms, Experimental/pathology*
;
Proto-Oncogene Proteins c-abl/metabolism*
;
Signal Transduction
;
Valproic Acid/pharmacology*
2.Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo.
Yanjing SONG ; Chuan TONG ; Yao WANG ; Yunhe GAO ; Hanren DAI ; Yelei GUO ; Xudong ZHAO ; Yi WANG ; Zizheng WANG ; Weidong HAN ; Lin CHEN
Protein & Cell 2018;9(10):867-878
Human epidermal growth factor receptor 2 (HER2) proteins are overexpressed in a high proportion of gastric cancer (GC) cases and affect the maintenance of cancer stem cell (CSC) subpopulations, which are used as targets for the clinical treatment of patients with HER2-positive GC. Despite improvements in survival, numerous HER2-positive patients fail treatment with trastuzumab, highlighting the need for more effective therapies. In this study, we generated a novel type of genetically modified human T cells, expressing a chimeric antigen receptor (CAR), and targeting the GC cell antigen HER2, which harbors the CD137 and CD3ζ moieties. Our findings show that the expanded CAR-T cells, expressing an increased central memory phenotype, were activated by the specific recognition of HER2 antigens in an MHC-independent manner, and effectively killed patient-derived HER2-positive GC cells. In HER2-positive xenograft tumors, CAR-T cells exhibited considerably enhanced tumor inhibition ability, long-term survival, and homing to targets, compared with those of non-transduced T cells. The sphere-forming ability and in vivo tumorigenicity of patient-derived gastric cancer stem-like cells, expressing HER2 and the CD44 protein, were also inhibited. Our results support the future development and clinical application of this adoptive immunotherapy in patients with HER2-positive advanced GC.
Animals
;
Humans
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasms, Experimental
;
immunology
;
pathology
;
therapy
;
Receptor, ErbB-2
;
immunology
;
Receptors, Antigen, T-Cell
;
immunology
;
Stomach Neoplasms
;
immunology
;
pathology
;
therapy
;
Tumor Cells, Cultured
3.In vitro antioxidant activity of phenolic-enriched extracts from Zhangping Narcissus tea cake and their inhibition on growth and metastatic capacity of 4T1 murine breast cancer cells.
Le YING ; De-Dong KONG ; Yuan-Yuan GAO ; Feng YAN ; Yue-Fei WANG ; Ping XU
Journal of Zhejiang University. Science. B 2018;19(3):199-210
Phenolics, as the main bioactive compounds in tea, have been suggested to have potential in the prevention of various human diseases. However, little is known about phenolics and their bioactivity in Zhangping Narcissue tea cake which is considered the most special kind of oolong tea. To unveil its bioactivity, three phenolic-enriched extracts were obtained from Zhangping Narcissue tea cake using ethyl acetate, n-butanol, and water. Their main chemical compositions and in vitro bioactivity were analyzed by high-performance liquid chromatography (HPLC) and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). The ethyl acetate fraction (ZEF) consisted of higher content of phenolics, flavonoids, procyanidins, and catechin monomers (including epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and gallocatechin gallate (GCG)) than n-butanol fraction (ZBF) and water fraction (ZWF). ZEF exhibited the strongest antioxidant capacity in vitro due to its abundant bioactive compounds. This was validated by Pearson correlation and hierarchical clustering analyses. ZEF also showed a remarkable inhibition on the growth, migration, and invasion of 4T1 murine breast cancer cells.
Animals
;
Antineoplastic Agents, Phytogenic/pharmacology*
;
Antioxidants/pharmacology*
;
Camellia sinensis/chemistry*
;
Cell Line, Tumor
;
Cell Movement/drug effects*
;
Cell Proliferation/drug effects*
;
Female
;
Mammary Neoplasms, Experimental/pathology*
;
Mice
;
Neoplasm Metastasis
;
Phenols/pharmacology*
;
Plant Extracts/pharmacology*
4.Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation.
Xiaojun LIU ; Shuguang JIANG ; Chongyun FANG ; Hua LI ; Xuhua ZHANG ; Fuqin ZHANG ; Carl H JUNE ; Yangbing ZHAO
Protein & Cell 2017;8(7):514-526
The generation of T cells with maximal anti-tumor activities will significantly impact the field of T-cell-based adoptive immunotherapy. In this report, we found that OKT3/IL-2-stimulated T cells were phenotypically more heterogeneous, with enhanced anti-tumor activity in vitro and when locally administered in a solid tumor mouse model. To further improve the OKT3/IL-2-based T cell manufacturing procedure, we developed a novel T cell stimulation and expansion method in which peripheral blood mononuclear cells were electroporated with mRNA encoding a chimeric membrane protein consisting of a single-chain variable fragment against CD3 and the intracellular domains of CD28 and 4-1BB (OKT3-28BB). The expanded T cells were phenotypically and functionally similar to T cells expanded by OKT3/IL-2. Moreover, co-electroporation of CD86 and 4-1BBL could further change the phenotype and enhance the in vivo anti-tumor activity. Although T cells expanded by the co-electroporation of OKT3-28BB with CD86 and 4-1BBL showed an increased central memory phenotype, the T cells still maintained tumor lytic activities as potent as those of OKT3/IL-2 or OKT3-28BB-stimulated T cells. In different tumor mouse models, T cells expanded by OKT3-28BB RNA electroporation showed anti-tumor activities superior to those of OKT3/IL-2 T cells. Hence, T cells with both a less differentiated phenotype and potent tumor killing ability can be generated by RNA electroporation, and this T cell manufacturing procedure can be further optimized by simply co-delivering other splices of RNA, thus providing a simple and cost-effective method for generating high-quality T cells for adoptive immunotherapy.
Animals
;
CD28 Antigens
;
genetics
;
immunology
;
Electroporation
;
Humans
;
Immunity, Cellular
;
Interleukin-2
;
immunology
;
K562 Cells
;
Mice
;
Muromonab-CD3
;
immunology
;
Neoplasms, Experimental
;
genetics
;
immunology
;
pathology
;
RNA, Messenger
;
genetics
;
immunology
;
T-Lymphocytes
;
immunology
;
Tumor Necrosis Factor Receptor Superfamily, Member 9
;
genetics
;
immunology
6.Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.
Xin LONG ; Jian WANG ; Jian-Ping ZHAO ; Hui-Fang LIANG ; Peng ZHU ; Qi CHENG ; Qian CHEN ; Yan-Hui WU ; Zhan-Guo ZHANG ; Bi-Xiang ZHANG ; Xiao-Ping CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(5):667-676
The function of the spleen in tumor development has been investigated for years. The relationship of the spleen with hepatocellular carcinoma (HCC), a huge health burden worldwide, however, remains unknown. The present study aimed to examine the effect of splenectomy on the development of HCC and the possible mechanism. Mouse hepatic carcinoma lines H22 and Hepa1-6 as well as BALB/c and C57 mice were used to establish orthotopic and metastatic mouse models of liver cancer. Mice were divided into four groups, including control group, splenectomy control group (S group), tumor group (T group) and tumor plus splenectomy group (T+S group). Tumor growth, metastases and overall survival were assessed at determined time points. Meanwhile, myeloid-derived suppressor cells (MDSCs) were isolated from the peripheral blood (PB), the spleen and liver tumors, and then measured by flow cytometery. It was found that liver cancer led to splenomegaly, and increased the percentage of MDSCs in the PB and spleen in the mouse models. Splenectomy inhibited the growth and progression of liver cancer and prolonged the overall survival time of orthotopic and metastatic models, which was accompanied by decreased proportion of MDSCs in the PB and tumors of liver cancer-bearing mouse. It was suggested that splenectomy could be considered an adjuvant therapy to treat liver cancer.
Animals
;
Carcinoma, Hepatocellular
;
physiopathology
;
surgery
;
Cell Line, Tumor
;
Flow Cytometry
;
Humans
;
Liver Neoplasms
;
physiopathology
;
surgery
;
Mice
;
Myeloid-Derived Suppressor Cells
;
pathology
;
Neoplasms, Experimental
;
physiopathology
;
surgery
;
Spleen
;
physiopathology
;
surgery
;
Splenectomy
;
methods
7.Effect of p27 gene combined with Pientzehuang (characters: see text) on tumor growth in osteosarcoma-bearing nude mice.
Shou-song REN ; Fang YUAN ; Ying-hong LIU ; Le-tian ZHOU ; Jun LI
Chinese journal of integrative medicine 2015;21(11):830-836
OBJECTIVETo observe the effect of p27 gene recombinant adenovirus combined with Chinese medicine Pientzehuang ([characters: see text]) on the growth of xenografted human osteosarcoma in nude mice.
METHODSTissue transplantation was used to construct the orthotopic model of human osteosarcoma Saos-2 cell in nude mice. Thirty tumor-bearing nude mice were randomly divided into 5 groups with 6 mice in each group: blank control group (model of osteosarcoma), empty vector group (recombinant adeno-associated virus-multiple cloning site), Pientzehuang group, p27 gene group and combined treatment group (p27 gene combined with Pientzehuang). The effect of combined treatment on human osteosarcoma was analyzed through the tumor formation, tumor volume and inhibition rate of tumor growth. The expression of p27 was measured by immunohistochemical staining and Western blot.
RESULTSThe orthotopic model of osteosarcoma in nude mice was successfully constructed. The general appearance of tumor-bearing nude mice in Pientzehuang and p27 gene groups was markedly improved compared with the blank control group; and in the combined treatment group it was significantly improved compared with the Pientzehuang and p27 gene groups. The tumor growth in the Pientzehuang and p27 gene groups was significantly inhibited compared with the blank control group P<0.05); while in the combined treatment group it was markedly inhibited compared with the Pientzehuang and p27 gene groups (P<0.05). The rates of tumor growth inhibition were 34.1%, 56.5% and 63.8% in the Pientzehuang, p27 gene and combined treatment groups, respectively. Meanwhile, the protein expression of p27 gene in the p27 gene group was significantly increased compared with the blank control group (P<0.05); and it was significantly increased in the combined treatment group compared with the p27 gene and Pientzehuang groups (P<0.05).
CONCLUSIONp27 gene introduced by adenovirus combined with Pientzehuang can inhibit the growth of human osteosarcoma cell Saos-2 in nude mice.
Adenoviridae ; Animals ; Blotting, Western ; Bone Neoplasms ; pathology ; Cell Line ; Cyclin-Dependent Kinase Inhibitor p27 ; genetics ; Drugs, Chinese Herbal ; pharmacology ; Humans ; Immunohistochemistry ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Osteosarcoma ; pathology ; Sarcoma, Experimental ; pathology ; Transplantation, Heterologous
8.Non-thermal effect of high-intensity focused ultrasound on ultrastructure and apoptosis in rabbit hepatic VX2 tumors.
Journal of Central South University(Medical Sciences) 2015;40(7):715-722
OBJECTIVE:
To observe the micromorphological changes of ultrastructure, apoptosis-related proteins expression and tumor cell apoptosis after ablation with the high-intensity focused ultrasound (HIFU), and to explore the mechanisms responsible for the thermal and non-thermal effect.
METHODS:
Forty rabbits with hepatic VX2 tumors were randomly divided into a thermal group (n=20) and a non-thermal group (n=20), and were subjected to HIFU ablation with thermal or non-thermal condition, respectively. Five animals in each group were sacrificed on the 1st, 3rd, 7th or 14th day after the ablation. The changes of ultrastructure, apoptosis-related proteins expression and tumor cell apoptosis were detected.
RESULTS:
The results of transmission electron microscope (TEM) revealed more severe injury on tissue and cells in the non-thermal group than that in the thermal group. The changes of apoptosis-related proteins expression and tumor cell apoptosis in transient zone were significantly different in comparison with that in the ablated area or peripheral area between the two groups. The expression of vascular endothelial growth factor (VEGF) was at low level on the 1st and 3rd day and elevated gradually on the 7th and 14th day, with no significant difference (all P>0.05). The expression of caspase-3 reached peak on the 3rd day and decreased on the 7th and 14th day. It was significantly higher in the non-thermal group than that in the thermal group on the 3rd and 7th day (all P<0.05). The expression of NF-κB was elevated from the 3rd day and reached peak on the 7th day while decreased on the 14th day. There was no significant difference at every time point between the 2 groups (all P>0.05). The apoptosis index in the non-thermal group and the thermal group on the 3rd and 7th day were (28.60±1.14)% vs (21.80±1.92)% and (21.00±1.58)% vs (14.80±1.48)%, respectively. It was higher in the non-thermal group than that in the thermal group (both P<0.01).
CONCLUSION
Both the thermal and the non-thermal effect of HIFU can induce apoptosis in transient zone, but the latter have a stronger effect.
Animals
;
Apoptosis
;
Caspase 3
;
metabolism
;
High-Intensity Focused Ultrasound Ablation
;
Liver Neoplasms
;
pathology
;
ultrastructure
;
NF-kappa B
;
metabolism
;
Neoplasms, Experimental
;
pathology
;
ultrastructure
;
Rabbits
;
Vascular Endothelial Growth Factor A
;
metabolism
9.Are cancer stem cells the sole source of tumor?
Min HU ; Fei-Xiang XIANG ; Yu-Fei HE
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(5):621-625
Tumors are believed to consist of a heterogeneous population of tumor cells originating from rare cancer stem cells (CSCs). However, emerging evidence suggests that tumor may also originate from non-CSCs. To support this viewpoint, we are here to present definitive evidence indicating that the number of tumorigenic tumor cells is greater than that of CSCs in tumor, and tumor can also derive from non-CSCs. To achieve this, an idealized mathematical model was employed in the present study and theoretical calculation revealed that non-CSCs could initiate the occurrence of tumor if their proliferation potential was adequate. Further, experimental studies demonstrated that 17.7%, 38.6% and 5.2% of tumor cells in murine B16 solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were potentially tumorigenic. Thus, based on the aforementioned findings, we propose that the scarce CSCs, if exist, are not the sole source of a tumor.
Algorithms
;
Animals
;
Carcinogenesis
;
pathology
;
Carcinoma, Lewis Lung
;
pathology
;
Cell Differentiation
;
Cell Line, Tumor
;
Cell Proliferation
;
Liver Neoplasms, Experimental
;
pathology
;
Melanoma, Experimental
;
pathology
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Models, Biological
;
Neoplasms, Experimental
;
pathology
;
Neoplastic Stem Cells
;
pathology
;
Time Factors
;
Tumor Stem Cell Assay
;
methods
10.Effect of spleen lymphocytes on the splenomegaly in hepatocellular carcinoma-bearing mice.
Jing Jing FANG ; Zhen Yuan ZHU ; Hui DONG ; Guo Qiang ZHENG ; An Guo TENG ; An Jun LIU
Biomedical and Environmental Sciences 2014;27(1):17-26
OBJECTIVETo study the effect of spleen lymphocytes on the splenomegaly by hepatocellular carcinoma-bearing mouse model.
METHODSCell counts, cell cycle distribution, the percentage of lymphocytes subsets and the levels of IL-2 were measured, and two-dimensional gel electrophoresis (2-DE) was used to investigate the relationship between spleen lymphocytes and splenomegaly in hepatocellular carcinoma-bearing mice.
RESULTSCompared with the normal group, the thymus was obviously atrophied and the spleen was significantly enlarged in the tumor-bearing group. Correlation study showed that the number of whole spleen cells was positively correlated with the splenic index. The cell diameter and cell-cycle phase distribution of splenocytes in the tumor-bearing group showed no significant difference compared to the normal group. The percentage of CD3+ T lymphocytes and CD8+ T lymphocytes in spleen and peripheral blood of tumor-bearing mice were substantially higher than that in the normal mice. Meanwhile, the IL-2 level was also higher in the tumor-bearing group than in the normal group. Furthermore, two dysregulated protein, β-actin and S100-A9 were identified in spleen lymphocytes from H22-bearing mice, which were closely related to cellular motility.
CONCLUSIONIt is suggested that dysregulated β-actin and S100-A9 can result in recirculating T lymphocytes trapped in the spleen, which may explain the underlying cause of splenomegaly in H22-bearing mice.
Animals ; Carcinoma, Hepatocellular ; complications ; Cell Cycle ; Female ; Liver Neoplasms ; complications ; Lymphocytes ; physiology ; Mice ; Mice, Inbred ICR ; Neoplasms, Experimental ; therapy ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Spleen ; cytology ; pathology ; Splenomegaly ; etiology ; therapy ; Thymus Gland

Result Analysis
Print
Save
E-mail